Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention
Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly( d,l-lactic-co-glycolic)acid (PLGA) microspheres using t...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2002-06, Vol.81 (3), p.307-319 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 319 |
---|---|
container_issue | 3 |
container_start_page | 307 |
container_title | Journal of controlled release |
container_volume | 81 |
creator | Castellanos, Ingrid J. Cruz, Gloydian Crespo, Rubén Griebenow, Kai |
description | Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly(
d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability. |
doi_str_mv | 10.1016/S0168-3659(02)00073-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71778124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365902000731</els_id><sourcerecordid>71778124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</originalsourceid><addsrcrecordid>eNqFkM9O3DAQhy1UVLbQR6DKpag9BDxxYjsnhFbbFgmJA_Ray2uPF6NsEuxkpTxX34NnqvePypGLPWN9P3v8EXIO9BIo8KuHtMic8ar-RovvlFLBcjgiM5CpKOu6-kBm_5ET8inG5wRVrBQfyQkUtCwrXs_In0VrdB_HRg--a3Pf2tGgzfRqFXC1O8t0a7OmizHzqTaD3_hhyjqXvf7NzdO07oYw9dHvueEJfcj6gBtst-Ezcux0E_HzYT8lv38sHue_8rv7n7fzm7vcsBqGnNmy4JKDYUWtKTOVrSvQyKiUjovUL4UGyYuSO1Y4W1K3dAwlF4BLKyVlp-Rif28fupcR46DWPhpsGt1iN0YlQAgJRZnAag-akL4U0Kk--LUOkwKqtmLVTqzaWlO0UDuxClLuy-GBcblG-5Y6mEzA1wOgo9GNC7o1Pr5xTEAtQSTues9h0rHxGFQ0Htsk3Qc0g7Kdf2eUf4ylllo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71778124</pqid></control><display><type>article</type><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</creator><creatorcontrib>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</creatorcontrib><description>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly(
d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/S0168-3659(02)00073-1</identifier><identifier>PMID: 12044569</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Biological and medical sciences ; Chymotrypsin - chemistry ; Drug Stability ; Excipients ; Excipients - chemistry ; General pharmacology ; Lactic Acid - chemistry ; Medical sciences ; Microencapsulation ; Microspheres ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyethylene Glycols - chemistry ; Polyglycolic Acid - chemistry ; Polymers - chemistry ; Protein aggregation ; Protein stabilization ; Protein Structure, Secondary ; Solid-in-oil-in-water (s/o/w) encapsulation procedure ; Trehalose - chemistry</subject><ispartof>Journal of controlled release, 2002-06, Vol.81 (3), p.307-319</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</citedby><cites>FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-3659(02)00073-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13719817$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12044569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castellanos, Ingrid J.</creatorcontrib><creatorcontrib>Cruz, Gloydian</creatorcontrib><creatorcontrib>Crespo, Rubén</creatorcontrib><creatorcontrib>Griebenow, Kai</creatorcontrib><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly(
d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</description><subject>Biological and medical sciences</subject><subject>Chymotrypsin - chemistry</subject><subject>Drug Stability</subject><subject>Excipients</subject><subject>Excipients - chemistry</subject><subject>General pharmacology</subject><subject>Lactic Acid - chemistry</subject><subject>Medical sciences</subject><subject>Microencapsulation</subject><subject>Microspheres</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polyglycolic Acid - chemistry</subject><subject>Polymers - chemistry</subject><subject>Protein aggregation</subject><subject>Protein stabilization</subject><subject>Protein Structure, Secondary</subject><subject>Solid-in-oil-in-water (s/o/w) encapsulation procedure</subject><subject>Trehalose - chemistry</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9O3DAQhy1UVLbQR6DKpag9BDxxYjsnhFbbFgmJA_Ray2uPF6NsEuxkpTxX34NnqvePypGLPWN9P3v8EXIO9BIo8KuHtMic8ar-RovvlFLBcjgiM5CpKOu6-kBm_5ET8inG5wRVrBQfyQkUtCwrXs_In0VrdB_HRg--a3Pf2tGgzfRqFXC1O8t0a7OmizHzqTaD3_hhyjqXvf7NzdO07oYw9dHvueEJfcj6gBtst-Ezcux0E_HzYT8lv38sHue_8rv7n7fzm7vcsBqGnNmy4JKDYUWtKTOVrSvQyKiUjovUL4UGyYuSO1Y4W1K3dAwlF4BLKyVlp-Rif28fupcR46DWPhpsGt1iN0YlQAgJRZnAag-akL4U0Kk--LUOkwKqtmLVTqzaWlO0UDuxClLuy-GBcblG-5Y6mEzA1wOgo9GNC7o1Pr5xTEAtQSTues9h0rHxGFQ0Htsk3Qc0g7Kdf2eUf4ylllo</recordid><startdate>20020617</startdate><enddate>20020617</enddate><creator>Castellanos, Ingrid J.</creator><creator>Cruz, Gloydian</creator><creator>Crespo, Rubén</creator><creator>Griebenow, Kai</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020617</creationdate><title>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</title><author>Castellanos, Ingrid J. ; Cruz, Gloydian ; Crespo, Rubén ; Griebenow, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-3d426861c329a03c5d951ae3088f673c5b7a186246f32fd40fbf3e8671ebd8803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Chymotrypsin - chemistry</topic><topic>Drug Stability</topic><topic>Excipients</topic><topic>Excipients - chemistry</topic><topic>General pharmacology</topic><topic>Lactic Acid - chemistry</topic><topic>Medical sciences</topic><topic>Microencapsulation</topic><topic>Microspheres</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polyglycolic Acid - chemistry</topic><topic>Polymers - chemistry</topic><topic>Protein aggregation</topic><topic>Protein stabilization</topic><topic>Protein Structure, Secondary</topic><topic>Solid-in-oil-in-water (s/o/w) encapsulation procedure</topic><topic>Trehalose - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castellanos, Ingrid J.</creatorcontrib><creatorcontrib>Cruz, Gloydian</creatorcontrib><creatorcontrib>Crespo, Rubén</creatorcontrib><creatorcontrib>Griebenow, Kai</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castellanos, Ingrid J.</au><au>Cruz, Gloydian</au><au>Crespo, Rubén</au><au>Griebenow, Kai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2002-06-17</date><risdate>2002</risdate><volume>81</volume><issue>3</issue><spage>307</spage><epage>319</epage><pages>307-319</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein γ-chymotrypsin has been encapsulated in poly(
d,l-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of γ-chymotrypsin. To achieve stabilization of γ-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When γ-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when γ-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12044569</pmid><doi>10.1016/S0168-3659(02)00073-1</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-3659 |
ispartof | Journal of controlled release, 2002-06, Vol.81 (3), p.307-319 |
issn | 0168-3659 1873-4995 |
language | eng |
recordid | cdi_proquest_miscellaneous_71778124 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Chymotrypsin - chemistry Drug Stability Excipients Excipients - chemistry General pharmacology Lactic Acid - chemistry Medical sciences Microencapsulation Microspheres Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polyethylene Glycols - chemistry Polyglycolic Acid - chemistry Polymers - chemistry Protein aggregation Protein stabilization Protein Structure, Secondary Solid-in-oil-in-water (s/o/w) encapsulation procedure Trehalose - chemistry |
title | Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A20%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Encapsulation-induced%20aggregation%20and%20loss%20in%20activity%20of%20%CE%B3-chymotrypsin%20and%20their%20prevention&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Castellanos,%20Ingrid%20J.&rft.date=2002-06-17&rft.volume=81&rft.issue=3&rft.spage=307&rft.epage=319&rft.pages=307-319&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/S0168-3659(02)00073-1&rft_dat=%3Cproquest_cross%3E71778124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71778124&rft_id=info:pmid/12044569&rft_els_id=S0168365902000731&rfr_iscdi=true |